Reply to 'pharmacokinetic concerns related to darunavir/ritonavir plus raltegravir combination therapy trial'

Edward P. Acosta; Babafemi Taiwo; Joseph J. Eron

doi:10.1097/QAD.0b013e32834e89ef

Reply to 'pharmacokinetic concerns related to darunavir/ritonavir plus raltegravir combination therapy trial'

Edward P. Acosta, Babafemi Taiwo^*, Joseph J. Eron

^*Corresponding author for this work

Medicine, Infectious Diseases Division

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	397-398
Number of pages	2
Journal	AIDS
Volume	26
Issue number	3
DOIs	https://doi.org/10.1097/QAD.0b013e32834e89ef
State	Published - Jan 28 2012

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/QAD.0b013e32834e89ef

Cite this

@article{d922fe6265d44b32bb1922790bb41579,

title = "Reply to 'pharmacokinetic concerns related to darunavir/ritonavir plus raltegravir combination therapy trial'",

author = "Acosta, {Edward P.} and Babafemi Taiwo and Eron, {Joseph J.}",

year = "2012",

month = jan,

day = "28",

doi = "10.1097/QAD.0b013e32834e89ef",

language = "English (US)",

volume = "26",

pages = "397--398",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Reply to 'pharmacokinetic concerns related to darunavir/ritonavir plus raltegravir combination therapy trial'

AU - Acosta, Edward P.

AU - Taiwo, Babafemi

AU - Eron, Joseph J.

PY - 2012/1/28

Y1 - 2012/1/28

UR - http://www.scopus.com/inward/record.url?scp=84855384906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855384906&partnerID=8YFLogxK

U2 - 10.1097/QAD.0b013e32834e89ef

DO - 10.1097/QAD.0b013e32834e89ef

M3 - Letter

AN - SCOPUS:84855384906

SN - 0269-9370

VL - 26

SP - 397

EP - 398

JO - AIDS

JF - AIDS

IS - 3

ER -

Reply to 'pharmacokinetic concerns related to darunavir/ritonavir plus raltegravir combination therapy trial'

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this